文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

大肠梗阻的当代管理:你需要知道什么

Contemporary management of large bowel obstruction: What you need to know.
PubMed 文献 · J Trauma Acute Care Surg · 2026-06-05
一句话结论大肠梗阻占肠梗阻约四分之一,CT是首选诊断手段,早期识别和干预可防止缺血、穿孔及脓毒症;稳定患者可短暂延迟干预以优化,但早期确定性处理应是常规路径。

本文综述了大肠梗阻的当代管理。大肠梗阻占所有肠梗阻约四分之一,可由良性或恶性机械性梗阻或功能性梗阻(如急性结肠假性梗阻)引起,临床可表现为急性腹痛、腹胀和便秘,或恶性梗阻的渐进性便秘和腹胀并导致脱水、电解质紊乱和营养不良。CT因能识别移行点、明确病因和严重程度并发现缺血或穿孔等并发症而成为首选诊断方式。内镜在部分患者中兼具诊断和治疗作用,包括乙状结肠扭转复位、假性梗阻减压、恶性梗阻的组织诊断或支架置入。初始管理聚焦复苏、纠正电解质紊乱、降低误吸风险和胃肠减压;确定性管理取决于病因,恶性梗阻需根据肿瘤位置、患者生理状态和机构专长个体化选择肿瘤切除伴或不伴造口、近端转流并分期切除或内镜支架置入后分期切除,自膨式金属支架可作为手术桥接并减少造口需求。

要点

  • 大肠梗阻占所有肠梗阻约四分之一;CT因能识别移行点、明确病因和严重程度并发现缺血或穿孔而成为首选诊断方式。
  • 急性梗阻典型表现为腹痛、腹胀和便秘;恶性梗阻常渐进起病,表现为进行性便秘和腹胀,可导致脱水、电解质紊乱和营养不良。
  • 内镜在部分患者中兼具诊断和治疗作用,包括乙状结肠扭转复位、假性梗阻减压、恶性梗阻的组织诊断或支架置入。
  • 初始管理聚焦复苏、纠正电解质紊乱、降低误吸风险和胃肠减压;确定性管理取决于病因。
  • 稳定患者可短暂延迟干预以优化,但早期确定性管理应是常规;延迟干预时必须仔细监测缺血或穿孔的发生。

适用人群与场景

  • 大肠梗阻患者,病因包括良性或恶性机械性梗阻,以及功能性梗阻如急性结肠假性梗阻。
  • 急性梗阻患者与恶性梗阻患者临床表现不同:急性者典型表现为腹痛、腹胀和便秘;恶性者常渐进起病,表现为进行性便秘和腹胀,可导致脱水、电解质紊乱和营养不良。

处置流程与药物剂量

  • 初始管理聚焦复苏、纠正电解质紊乱、降低误吸风险和胃肠减压。
  • CT为首选诊断方式,用于识别移行点、明确梗阻病因和严重程度,并发现缺血或穿孔等并发症。
  • 内镜在部分患者中兼具诊断和治疗作用,包括乙状结肠扭转复位、假性梗阻减压、恶性梗阻的组织诊断或支架置入。
  • 恶性大肠梗阻的确定性管理需根据肿瘤位置、患者生理状态和机构专长个体化规划,选项包括肿瘤切除伴或不伴造口、近端手术转流并分期切除,或内镜支架置入后分期切除。
  • 自膨式金属支架可作为手术桥接并减少造口需求。
  • 良性病因包括憩室狭窄、扭转、炎症性肠病相关狭窄、吻合口狭窄和粪便嵌塞,需个体化内镜或手术干预。
  • 稳定患者可短暂延迟干预以优化,但早期确定性管理应是常规路径;延迟干预时必须仔细监测缺血或穿孔的发生。

红旗征与不能漏的情况

  • 缺血和穿孔是可导致脓毒症和死亡的大肠梗阻并发症,需早期识别和及时评估以预防,延迟干预时必须仔细监测其发生。

证据类型、等级与局限

  • 综述。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • CT作为大肠梗阻首选诊断方式,用于识别移行点、明确病因和严重程度并发现缺血或穿孔,适用于疑似大肠梗阻患者的评估。
  • 初始管理包括复苏、纠正电解质紊乱、降低误吸风险和胃肠减压。
  • 恶性大肠梗阻的确定性管理需根据肿瘤位置、患者生理状态和机构专长个体化选择肿瘤切除伴或不伴造口、近端转流并分期切除或内镜支架置入后分期切除;自膨式金属支架可作为手术桥接并减少造口需求。
  • 稳定患者可短暂延迟干预以优化,但早期确定性管理应是常规路径;延迟干预时必须仔细监测缺血或穿孔的发生。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「研究设计与关键结果」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Large bowel obstruction (LBO) accounts for approximately one-quarter of all intestinal obstructions. LBO may arise from mechanical obstruction due to benign or malignant etiologies, or from functional obstruction such as acute colonic pseudo-obstruction. Because clinical presentation varies by acuity, etiology, and ileocecal valve competency, early recognition and prompt evaluation are essential to prevent complications, including ischemia and perforation with potential for sepsis and mortality. Patients with acute obstruction typically present with abdominal pain, distension, and obstipation, whereas malignant obstruction often develops gradually with progressive constipation and abdominal distension, leading to dehydration, electrolyte abnormalities, and malnutrition. Computed tomography has become the preferred diagnostic modality due to its ability to identify the transition point, help define the cause and severity of obstruction, and potentially detect complications such as ischemia or perforation. Endoscopy serves both diagnostic and therapeutic roles in selected patients, including detorsion for sigmoid volvulus, decompression for pseudo-obstruction, and tissue diagnosis or stent placement in malignant obstruction. Initial management focuses on resuscitation, correction of electrolyte abnormalities, mitigation of aspiration risk, and gastrointestinal decompression. Definitive management depends on the underlying etiology. Malignant LBO requires individualized planning based on tumor location, patient physiology, and institutional expertise, with options including oncologic resection with or without colostomy, proximal surgical diversion and staged resection, or endoscopic stenting with staged resection. Self-expanding metallic stents may serve as bridges to surgery and reduce the need for a stoma. Benign causes, including diverticular strictures, volvulus, inflammatory bowel disease-related strictures, anastomotic strictures, and fecal impaction, require tailored endoscopic or operative interventions. Across etiologies, short delays to intervention may be appropriate for stable patients undergoing optimization; however, early definitive management should be the usual approach. In cases where intervention is delayed, careful surveillance for developing ischemia or perforation is mandatory. ( J Trauma Acute Care Surg . 2026;101: 1-12. Copyright © 2026 Wolters Kluwer Health, Inc. All rights reserved).

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Mathew PJ, Schuster KM. Contemporary management of large bowel obstruction: What you need to know. J Trauma Acute Care Surg. 2026. PMID: 42246394. doi:10.1097/TA.0000000000004960

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。